Show simple item record

dc.contributor.authorCook, Judith A
dc.contributor.authorBurke-Miller, Jane K
dc.contributor.authorCohen, Mardge H
dc.contributor.authorCook, Robert L
dc.contributor.authorVlahov, David
dc.contributor.authorWilson, Tracey E
dc.contributor.authorGolub, Elizabeth T
dc.contributor.authorSchwartz, Rebecca M
dc.contributor.authorHoward, Andrea A
dc.contributor.authorPonath, Claudia
dc.contributor.authorPlankey, Michael W
dc.contributor.authorLevine, Andrea
dc.contributor.authorGrey, Dennis D
dc.date.accessioned2023-11-13T18:25:09Z
dc.date.available2023-11-13T18:25:09Z
dc.date.issued2008-07-11
dc.identifier.citationCook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE, Golub ET, Schwartz RM, Howard AA, Ponath C, Plankey MW, Levine AM, Grey DD. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS. 2008 Jul 11;22(11):1355-63. doi: 10.1097/QAD.0b013e32830507f2. Erratum in: AIDS. 2008 Sep 12;22(14):i. Levine, Andrea [corrected to Levine, Alexandra M]. PMID: 18580615; PMCID: PMC2645902.en_US
dc.identifier.issn0269-9370
dc.identifier.doi10.1097/qad.0b013e32830507f2
dc.identifier.pmid18580615
dc.identifier.urihttp://hdl.handle.net/20.500.12648/13906
dc.description.abstractBackground: Longitudinal associations between patterns of crack cocaine use and progression of HIV-1 disease are poorly understood, especially among women. This study explores relationships between crack use and HIV-1 disease outcomes in a multicenter cohort of infected women. Methods: Subjects were 1686 HIV-seropositive women enrolled at six US research centers in the Women's Interagency HIV Study. Approximately 80% were non-white and 29% used crack during the study period. Cox survival and random regression analysis examined biannual observations made April 1996 through September 2004. Outcome measures included death due to AIDS-related causes, CD4 cell count, HIV-1 RNA level, and newly acquired AIDS-defining illnesses. Results: Persistent crack users were over three times as likely as non-users to die from AIDS-related causes, controlling for use of HAART self-reported at 95% or higher adherence, problem drinking, age, race, income, education, illness duration, study site, and baseline virologic and immunologic indicators. Persistent crack users and intermittent users in active and abstinent phases showed greater CD4 cell loss and higher HIV-1 RNA levels controlling for the same covariates. Persistent and intermittent crack users were more likely than non-users to develop new AIDS-defining illnesses controlling for identical confounds. These results persisted when controlling for heroin use, tobacco smoking, depressive symptoms, hepatitis C virus coinfection, and injection drug use. Conclusion: Use of crack cocaine independently predicts AIDS-related mortality, immunologic and virologic markers of HIV-1 disease progression, and development of AIDS-defining illnesses among women.en_US
dc.language.isoenen_US
dc.publisherOvid Technologies (Wolters Kluwer Health)en_US
dc.relation.urlhttps://journals.lww.com/aidsonline/fulltext/2008/07110/crack_cocaine,_disease_progression,_and_mortality.13.aspxen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectInfectious Diseasesen_US
dc.subjectImmunologyen_US
dc.subjectImmunology and Allergyen_US
dc.titleCrack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive womenen_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleAIDSen_US
dc.source.volume22
dc.source.issue11
dc.source.beginpage1355
dc.source.endpage1363
dc.description.versionVoRen_US
refterms.dateFOA2023-11-13T18:25:12Z
dc.description.institutionSUNY Downstateen_US
dc.description.departmentCommunity Health Sciencesen_US
dc.description.degreelevelN/Aen_US
dc.identifier.issue11en_US


Files in this item

Thumbnail
Name:
crack_cocaine,_disease_progres ...
Size:
168.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International